Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
…
continue reading
In this podcast by Healio, host Shikha Jain, MD, FACP, covers modern day health care in an ever-evolving world. Through interviews with experts, Jain explores hot topics in oncology and beyond.
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
…
continue reading
JCO's Award Winning podcast Cancer Stories: The Art of Oncology features stories, dialogue, and personal reflections that explore the experience of living with cancer or caring for people with cancer, hosted by Dr. Lidia Schapira.
…
continue reading
The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results published in ASCO’s Journal of Clinical Oncology.
…
continue reading
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and sta ...
…
continue reading
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
Welcome to Integrative Oncology Talk! Where we discuss the latest science and opinions from leading voices in integrative oncology. Integrative oncology utilizes complementary therapies and lifestyle strategies to help those affected by cancer, using personalized approaches and evidence based recommendations. This podcast is hosted by Dr. Santosh Rao, a medical oncologist and integrative oncologist. Dr. Judith Lacey, a supportive care and integrative oncology physician. And Leigh Leibel (pro ...
…
continue reading
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
JCO OP: Put Into Practice highlights new research published in JCO OP related to cancer care delivery, quality, disparities, access. Host Dr. Fumiko Chino, MD FASCO interviews thought leaders in oncology to give listeners practical knowledge that can be used in day-to-day practice along with solution-oriented discussions and care innovations.
…
continue reading
The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest ...
…
continue reading
The Academy of Oncology Nurse & Patient Navigators (AONN+) is proud to present the Heart and Soul of Navigation podcast series! Once a month, we will release a new episode that features key opinion leaders in oncology navigation highlighting stories from the front lines, best practices and lessons learned throughout their careers, and resources and support services. Heart and Soul of Oncology Navigation provides a platform for navigators to discuss topics within 8 domains of knowledge: Commu ...
…
continue reading
OncoTalks are 10-15 minute educational podcasts featuring experts from The US Oncology Network, highlighting new treatments, indications and the latest advancements in oncology.
…
continue reading
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
…
continue reading
All Talk Oncology is a Cancer Podcast that empowers cancer patients through insightful conversations that reinforces confidence and certainty about their cancer condition. Transforming a terrifying experience into a manageable one, by arming patients with the understanding they need, and the ability to take control of their treatments through knowledge, allowing effective interaction with their medical team.
…
continue reading
Rehabilitation Oncology is an indexed resource for the dissemination of peer-reviewed research-based evidence related to oncologic physical therapy and cancer rehabilitation. The journal provides a forum for scientific and professional exchange among researchers and practitioners throughout the world. The journal serves as the official journal for the Academy of Oncologic Physical Therapy. High standards of quality are maintained through a rigorous, double-blinded peer-review process and adh ...
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
The Oncology Podcast including Supportive Care Matters by Dr. Bogda Koczwara, are brought to you by The Oncology Network. The Oncology Network are producers of digital resources that support busy oncology health professionals. For more information visit our website www.oncologynews.com.au. We also invite Healthcare Professionals to subscribe to The Oncology Newsletter and our Oncology Portal for free and exclusive resources at: www.oncologynetwork.com.au
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
Oncology Information Group is a global resource for the latest updates in oncology advancements. Subscribe to our podcast to receive the latest updates as they become available.
…
continue reading
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoke ...
…
continue reading
learn bite-sized information about different aspects of hematology and oncology.
…
continue reading
An academic platform for discussion of the latest and greatest updates in the ever evolving field of Medical Oncology and Clinical Hematology. Contact [email protected]
…
continue reading
This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
…
continue reading
Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer
…
continue reading
Outspoken Oncology, hosted by Chadi Nabhan, MD, MBA, FACP, is dedicated to facilitating candid discussion among all stakeholders on the most pressing—and often controversial—topics in cancer care today.
…
continue reading
Fast Facts Oncology is a must listen for busy clinicians, allowing them to get quickly up-to-speed on the latest developments from the field.
…
continue reading
A podcast for uro-oncologists developing a deeper understanding of the literature to ensure we apply the right evidence to the right patient.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies
2:01:57
2:01:57
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
2:01:57Featuring slide presentations and related discussion from Dr Joyce O'Shaughnessy, Dr Mark Pegram and Prof Peter Schmid, including the following topics: Strategies to Identify Patients with HER2-Low and HER2-Ultralow Breast Cancer (0:00) Case: A woman in her mid 50s initially presenting with ER-positive, HER2 IHC 1+ locally advanced breast cancer wh…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mara B. Antonoff, MD, FACS / Karen L. Reckamp, MD - Targeting Higher Standards in Resectable NSCLC: The Surgery-Oncology Coalition for Tailoring Care in EGFR and ALK TKI Therapy
53:25
53:25
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
53:25This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/RDK865. CME…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A Look Into Cancer Advocacy & Patient Education (CAPE)
15:23
15:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
15:23In this episode, Emily Gentry, BSN, RN, HON-ONN-CG, OCN, and Chelsea Passwater DNP, RN, AGCNS-BC, OCN, discuss the benefits and background of the Cancer Advocacy & Patient Education (CAPE) Portal. Thank you to our sponsor, Exelixis, for providing funding for this podcast.The Academy of Oncology Nurse & Patient Navigators による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer
12:12
12:12
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
12:12Host Dr. Shannon Westin and guests Dr. Bill Aronson discuss the article "High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial" and how Omega-6 are predominant in the American diet while the study significantly lowered the intake of Omega- 6 fats. TRANSCRIPT Dr. Sha…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
46:45
46:45
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
46:45Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York discusses available data guiding treatment decision-making for patients with newly diagnosed multiple myeloma. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep148: Navigating Management and Dosing Considerations for Amivantamab in NSCLC
26:34
26:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
26:34In the first edition of a special 3-part podcast series, CancerNetwork® spoke with Daniel Morgensztern, MD; Mary Ellen Flanagan, NP; and Janelle Mann, PharmD, BCOP, about best practices for implementing recently approved bispecific antibodies into cancer care. Their initial discussion focused on the clinical trial results, administration protocols,…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting
20:01
20:01
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
20:01In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recently presented at the 2024 annual American Society of Hematology meeting, including: Early results with teclistamab combined with anti-CD38 therapy Real-world data with teclistamab including its use aft…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
From Glass Slides to AI: How Digital Pathology and MRD Testing Are Transforming Cancer Care With Osama Khan, MD, and Waqas Haque, MD, MPH
21:50
21:50
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
21:50In this episode of the Exploring Artificial Intelligence (AI) in Oncology series, Waqas Haque, MD, MPH, Hematology/Oncology Fellow at the University of Chicago, speaks with Osama Khan, MD, Staff Pathologist at Natera, a cell-free DNA (cfDNA) technology company that aims to make personalized genetic testing and diagnostics part of the standard of ca…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Survivorship and Visual Storytelling with Anna Rathkopf
35:41
35:41
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
35:41In this episode, host Shikha Jain, MD, speaks with Anna Rathkopf about the mental and physical toll of cancer treatment and survivorship, using photography to connect with patients and caregivers and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Rathkopf 0:20 • The interview 1:23 • How did you get into storytelling …
…
continue reading
Professor Ian Tannock (Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada) discusses his Policy Review on Common Sense Oncology principles for the design, analysis and reporting of phase 3 randomised clinical trials.The Lancet による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials
18:03
18:03
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
18:03Professor Ian Tannock (Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada) discusses his Policy Review on Common Sense Oncology principles for the design, analysis and reporting of phase 3 randomised clinical trials. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... h…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
11:55
11:55
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
11:55Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Oncologists Overtreat Patients at End of Life
10:45
10:45
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
10:45When it comes to end-of-life care for patients with cancer, “I think that there is a real deficit in our training,” says Nathan I. Cherny, MD, director of the Cancer Pain and Palliative Medicine Service at Shaare Zedek Medical Center in Jerusalem, Israel. Dr. Cherney and colleagues recently examined factors contributing to oncologists overtreating …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
You Don't Bring Me Flowers: Hospital Policy vs. Patient Joy
20:34
20:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
20:34Listen to ASCO’s Journal of Clinical Oncology Art of Oncology article, "You Don't Bring Me Flowers” by Dr. Kathryn Cappell, who is an Assistant Research Physician at the National Cancer Institute. The article is followed by an interview with Cappell and host Dr. Mikkael Sekeres. Dr Cappell shares the difficulty in protecting oncology patients witho…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma
7:33
7:33
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
7:33The pivotal role of programmed death-ligand 1 (PD-L1) checkpoint inhibition for treating advanced melanoma has been confirmed in findings from the KEYNOTE-006 study comparing the anti-PD-L1 antibody pembrolizumab immunotherapy with the anti-cytotoxic T-lymphocyte associated protein 4 (CTLA-4) drug ipilimumab for treating patients with unresectable …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Debt or Dying: The JCO OP Financial Toxicity Special Issue
30:51
30:51
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
30:51Host Dr. Fumiko Chino sits down with co-editor and health outcomes researcher Dr. Ryan Nipp, and contributing author Dr. Kelly Shanahan who is living with metastatic breast cancer to have a candid conversation about financial toxicity, the lived experience for patients, and what we can do to move the needle on affordability in cancer care. TRANSCRI…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Management of Cancer Related Fatigue w/ Karen Mustian, Lead Author of SIO-ASCO Fatigue Guidelines
30:47
30:47
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
30:47In this episode of Integrative Oncology Talk, hosts Dr. Judith Lacey and Karen discuss the role of integrative therapies in cancer care, focusing on the treatment and management of cancer-related fatigue. They examine the evolution of exercise and yoga in integrative oncology, the development of ASCO and SIO guidelines, and the efficacy of non-phar…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AUDIO JOURNAL OF ONCOLOGY: Randomized Study Found Surgery-Sparing Active Monitoring Safe in Patients With Low-risk DCIS
13:47
13:47
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
13:47SAN ANTONIO, USA—In patients with hormone receptor-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS) active monitoring, compared with surgery, resulted in no difference in terms of cancer outcomes in the multicenter, randomized COMET study that compared oncologic outcomes of patients randomized to guideline-concordant care (with sur…
…
continue reading